Crossmark

Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials

Published Online: 2026-04-13

Authors

Strikić, Mia https://orcid.org/0000-0002-3905-7069
Pranić, Shelly Melissa https://orcid.org/0000-0001-5524-1723
License Information

Text and Data Mining valid from 2026-04-13

Version of Record valid from 2026-04-13
More Information

Article History

Received: 8 December 2025

Accepted: 8 March 2026

First Online: 13 April 2026

Declarations

:

: The authors declare no competing interests.

: There was no need for ethics approval since we did not include any participants or animals in our cross-sectional study.

Document is current